Charles Schwab’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $887M | Sell |
|
|||||
|
2025
Q1 | $898M | Buy |
|
|||||
|
2024
Q4 | $739M | Buy |
|
|||||
|
2024
Q3 | $650M | Buy |
|
|||||
|
2024
Q2 | $516M | Buy |
|
|||||
|
2024
Q1 | $540M | Buy |
|
|||||
|
2023
Q4 | $590M | Buy |
|
|||||
|
2023
Q3 | $539M | Sell |
|
|||||
|
2023
Q2 | $559M | Sell |
|
|||||
|
2023
Q1 | $614M | Sell |
|
|||||
|
2022
Q4 | $648M | Buy |
|
|||||
|
2022
Q3 | $458M | Buy |
|
|||||
|
2022
Q2 | $440M | Sell |
|
|||||
|
2022
Q1 | $431M | Buy |
|
|||||
|
2021
Q4 | $525M | Buy |
|
|||||
|
2021
Q3 | $493M | Buy |
|
|||||
|
2021
Q2 | $478M | Buy |
|
|||||
|
2021
Q1 | $414M | Sell |
|
|||||
|
2020
Q4 | $381M | Buy |
|
|||||
|
2020
Q3 | $412M | Sell |
|
|||||
|
2020
Q2 | $531M | Sell |
|
|||||
|
2020
Q1 | $533M | Buy |
|
|||||
|
2019
Q4 | $457M | Buy |
|
|||||
|
2019
Q3 | $439M | Buy |
|
|||||
|
2019
Q2 | $458M | Buy |
|
|||||
|
2019
Q1 | $432M | Buy |
|
|||||
|
2018
Q4 | $379M | Buy |
|
|||||
|
2018
Q3 | $450M | Buy |
|
|||||
|
2018
Q2 | $387M | Buy |
|
|||||
|
2018
Q1 | $394M | Buy |
|
|||||
|
2017
Q4 | $370M | Buy |
|
|||||
|
2017
Q3 | $402M | Buy |
|
|||||
|
2017
Q2 | $333M | Buy |
|
|||||
|
2017
Q1 | $299M | Buy |
|
|||||
|
2016
Q4 | $305M | Buy |
|
|||||
|
2016
Q3 | $321M | Sell |
|
|||||
|
2016
Q2 | $400M | Sell |
|
|||||
|
2016
Q1 | $459M | Sell |
|
|||||
|
2015
Q4 | $523M | Buy |
|
|||||
|
2015
Q3 | $501M | Buy |
|
|||||
|
2015
Q2 | $586M | Buy |
|
|||||
|
2015
Q1 | $486M | Buy |
|
|||||
|
2014
Q4 | $455M | Buy |
|
|||||
|
2014
Q3 | $442M | Buy |
|
|||||
|
2014
Q2 | $312M | Buy |
|
|||||
|
2014
Q1 | $256M | Buy |
|
|||||
|
2013
Q4 | $251M | Buy |
|
|||||
|
2013
Q3 | $204M | Buy |
|
|||||
|
2013
Q2 | $162M | Buy |
|